Korean Biotech Roundup: GNT Set For First Direct Korean Biopharma IPO On Nasdaq
Others Sign Big Deals With Multinationals
GNT Pharma prepares for the first listing of a Korean biotech on Nasdaq, while others sign major global out-licensing deals with large multinational partners.
